Volume 2: Issue 4

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

Michael McGoon, MD, SLC Chair, Pulmonary Hypertension Clinic, Mayo Clinic, Rochester, Minnesota
Robyn J. Barst, MD, SLC Vice-Chair, New York Presbyterian Pulmonary Hypertension Center, Columbia University College of Physicians and Surgeons, New York, New York
David B. Badesch, MD, Chair, SLC Nominations Committee, University of Colorado Health Sciences Center, Denver, Colorado
Joy Beckmann, RN, MSN, Pulmonary Hypertension Program, Harbor-UCLA Medical Center, Torrance, California
C. Gregory Elliott, MD, Chair, SLC Publications Committee,

This discussion was moderated by Sean Gaine, MD, Director, Pulmonary Hypertension Unit, Mater Misericordiae Hospital, University College, Dublin, Ireland. The physicians participating included Stuart Rich, MD, Professor of Medicine, and Director, Rush Heart Institute Center for Pulmonary Heart Disease, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois, Norbert Voelkel, MD, The Hart Family Professor of Emphysema Research, University of Colorado Health Sciences Center, Denver, Colorado, and Nicholas W. Morrell, MD, Director, Pulmonary Vascular Diseases Unit, Papworth and Addenbrooke's Hospitals, University of Cambridge School of Clinical Medicine, Cambridge, UK.

The Scientific Leadership Council of the Pulmonary Hypertension Association

Predicting Future Directions in Pulmonary Hypertension

In the Pantheon of PH Research, Tim Higenbottam Sets the Pace

Severe Angioproliferative Pulmonary Hypertension: The Lung Circulation Between Vasoconstriction and Cancer

Analysis of Lung Tissue in Severe Pulmonary Hypertension Has Changed Concepts of Pathogenesis

What's on the Horizon in Therapy, From Current Approaches to Experimental Agents

New Directions in Pulmonary Hypertension: Expanding the Spectrum of End Points to Enhance Clinical Evaluation

Future Directions: An Expert Panel Explores the Challenge of Halting Progression and Reversing the Pathology of PAH

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease